Risk factors and clinical responses of pneumonia patients with colistin-resistant<i>Acinetobacter baumannii-calcoaceticus</i>

Abstract

The optimal therapy regimen is unclear for colistin-resistant <i>Acinetobacter sp</i>. infections. Although combinations with sulbactam seems to be more effective in our study patients, data supporting the usefulness of combinations with sulbactam is very limited.